In the acute phase of CI, IGFBP-3 and ALS levels typically decline early in the course of illness and remain low due to peripheral GH resistance, reduced GH receptor expression, and impaired hepatic synthesis and release of IGF-1 and IGFBP-3 [8,11]. This evidence concerns the gene GH1 and amyotrophic lateral sclerosis.